Adjuvant Endocrine Therapy Choices in Premenopausal Patients with Hormone Receptor-Positive Early Breast Cancer: Results from the Prospective Gim23-Poster Study
Luca Arecco(Ospedale Policlinico San Martino), Lucia Del Mastro(Ospedale Policlinico San Martino), Francesca Poggio(Ospedale Policlinico San Martino), Eleonora Mioranza(Istituti di Ricovero e Cura a Carattere Scientifico), Fabio Puglisi(University of Udine), Sara Donati(Ospedale Versilia), Filippo Giovanardi, Eva Blondeaux(Ospedale Policlinico San Martino), Sara Piccinini(Ospedale Policlinico San Martino), Valentina Guarneri(Istituto Oncologico Veneto), Elisabetta Landucci(Azienda Ospedaliera Universitaria Pisana), Giancarlo Bisagni, Laura Biganzoli(Hospital of Prato), Vincenzo Adamo(University of Messina), Alexandro Membrino(Istituti Ospitalieri di Cremona), Maria Maddalena Latocca(Ospedale Policlinico San Martino), Evandro de Azambuja(Université Libre de Bruxelles), Matteo Lambertini(Ospedale Policlinico San Martino), Elisa Gasparini(Azienda Sanitaria Unità Locale di Reggio Emilia), Carmela Mocerino(Ospedale Antonio Cardarelli), Antonella Ferro(Ospedale Santa Chiara), Stefano Tamberi(Azienda Unità Sanitaria Locale Della Romagna), Simona Pastorino(Ospedale Policlinico San Martino), Ferdinando Riccardi(Ospedale Antonio Cardarelli)
Cited by 0
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)
|Annals of Oncology|2016|2.1k
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer
|Annals of Oncology|2021|1.4k
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
|Annals of Oncology|2020|1.4k
4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)
|Annals of Oncology|2018|1.2k